ロード中...
MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma
Immune checkpoint blockade (ICB) has demonstrated an impressive outcome in patients with metastatic melanoma, yet, durable complete response; even with Ipilimumab/Nivolumab combo are under 30%. Primary and acquired resistance in response to ICB is commonly due to a tumor immune escape mechanism dict...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7733907/ https://ncbi.nlm.nih.gov/pubmed/33344042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1846915 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|